ID93/GLA-SE

ID93/GLA-SE is a vaccine designed to protect against tuberculosis (TB), a serious infectious disease. It combines two components: ID93, a protein from the TB bacteria that prompts an immune response, and GLA-SE, an adjuvant that enhances this response by stimulating the immune system. When administered, the vaccine trains the body's defenses to recognize and fight TB bacteria more effectively, aiming to prevent infection or reduce disease severity. It is part of ongoing efforts to improve TB prevention, especially in areas where the disease is common.